000			03144nam a22002537a 4500
003			OSt
005			20240305192458.0
008			220615b |||||||| |||| 00| 0 eng d
020			_a1437737714
020			_a 9781437737714
040			_cdlc
082			_a616.61
100			_a Jonathan Himmelfarb _925854
245			_aChronic Kidney Disease, Dialysis, and Transplantation _b A Companion to Brenner and Rector’s The Kidney
250			_a3rd edition
260			_aPhiladelphia _bElsevier Health Sciences _c2010
300			_a 760 pages
505			_aContents: Complications and Management of Chronic Kidney Disease Hemodialysis Peritoneal Dialysis Transplantation Acute Kidney Injury Index
520			_aChronic Kidney Disease, Dialysis, and Transplantation—a companion to Brenner and Rector’s The Kidney—covers all clinical management issues relevant to chronic kidney disease. Drs. Jonathan Himmelfarb and Mohamed Sayegh lead a team of expert contributors to present you with the latest advances in hypertensive kidney disease, vitamin D deficiency, diabetes management, transplantation, and more. Apply the expertise of distinguished researchers and clinicians in the fields of hemodialysis, peritoneal dialysis, critical care nephrology, and transplantation. Manage the full range of issues in chronic kidney disease, dialysis, and transplantation through comprehensive coverage of basic science and clinical tools. Gain clear visual understanding from illustrations, including diagnostic and treatment algorithms, line drawings, and photographs. Better manage your patients with up-to-date coverage on the latest advances in 13 new chapters including Hypertensive Kidney Disease, Vitamin D Deficiency, Diabetes Management, and more. Gain fresh perspectives from a revised editorial team led by Jonathan Himmelfarb—a young leader in the field of acute renal failure—and Mohamed Sayegh—a worldwide expert on kidney transplantation. _bCommon terms and phrases: acid activity addition agents assessed associated benefit blood blood pressure body bone calcium cardiovascular catheter cause cells changes Chronic Kidney Disease clearance clinical compared concentration creatinine death decreased demonstrated diabetes dialysis dialysis patients dose effects ESRD estimated evaluation evidence factors failure Figure flow fluid frequent function glucose graft greater hemodialysis higher hypertension important improved incidence increased indicate individuals infection initiation intake lead less levels loss lower marker measured medications membrane mortality myocardial infarction normal nutritional observed occur outcomes patients peritoneal plasma population potential prevalence prevent progression protein randomized recent recommended reduced removal renal reported risk serum showed shown significant sleep solute stage studies suggest Table therapy tion transplant transport treated treatment trial United urea uremic vascular vitamin volume
600			_x Medical / Nephrology _928626
600			_x Medical › Nephrology _928627
700			_aMohamed H. Sayegh _939095
942			_2ddc _cEB
999			_c7233 _d7233